Oral GLP-1s: Is FDA Approval on the Horizon?

Topic of the Month on ModernWeight: Benefits!

Head to the Social Hub to chat on the benefits of GLP-1 medications, including but not limited to weight loss.

AOMs in the News

Pfizer Advances Daily Oral GLP-1 Research

Link: PharmaNewsIntel Article

Pfizer is making strides in developing a daily oral GLP-1 medication. This new form could simplify treatment and improve adherence for those managing obesity with GLP-1 drugs.

Tirzepatide vs. Semaglutide: Real-World Weight Loss Results

Link: Healio Article

A new study shows that Tirzepatide leads to greater real-world weight loss compared to Semaglutide for adults with obesity. This finding may influence treatment choices and patient outcomes in obesity management.

85% of Patients Stop GLP-1s After 2 Years

Link: Forbes Article

A recent study reveals that 85% of patients discontinue GLP-1 medications for weight loss after two years. Common reasons for this high dropout rate include side effects, cost, and perceived lack of efficacy. Understanding these factors is crucial for improving long-term adherence and success.

New Discovery Could Eliminate Nausea from GLP-1 Drugs

Link: ScienceBlog Article

Researchers have identified a way to eliminate the nausea often caused by GLP-1 weight loss drugs. This breakthrough could enhance patient comfort and compliance with these effective treatments.

Brain Cells That Delay Hunger Identified

Link: Medical Xpress Article

Scientists have discovered specific brain cells that delay hunger after eating. This finding could lead to new weight management strategies that harness the body's natural hunger signals.

Expert Tweet of the Week

From @WIRED

"When drugs are officially in shortage the US allows pharmacies to make their own legalized dupes. Telehealth startups have jumped into the GLP-1 marketplace to sell these compounded drugs offering easy-to-access copies at a far more affordable price."

Read more

---

Our ModernWeight "Weekly Weight Management Insights" newsletter is designed to keep you informed and engaged with the latest in weight management and GLP-1 medications. Visit the Social Hub to join the conversation and connect with our community.

Want to receive this newsletter in your inbox weekly? Create a profile!